Novartis Investigative Site

Heidelberg 3084

0 studies enrolling now · 3 studies all time

What they study most

Islet Cell Carcinoma, Neoplasms, Breast, Neuroendocrine Carcinoma, Neuroendocrine Tumor, Non-Small Cell Lung Cancer, Pancreatic Neoplasms

Studies at this site

• ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D — Completed
• ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung Cancer — Stopped early
• Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy — Completed